Valuation : Star Scientific, Inc.

Market Cap 153K 132K 124K 113K 212K 14.48M 213K 1.47M 569K 7.43M 576K 563K 23.94M P/E 2014
-0.87x
P/E 2015 -1.04x
Enterprise Value 20.01M 17.22M 16.2M 14.8M 27.68M 1.89B 27.76M 191M 74.29M 969M 75.14M 73.5M 3.12B EV / Sales 2014
-
EV / Sales 2015 -
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.88%-2.15%+54.71%+106.31% 1,024B
-1.15%+2.68%+53.97%+71.50% 663B
-1.44%+0.38%+20.40%+73.05% 453B
+0.14%-0.47%+29.49%+38.56% 352B
-1.33%+4.72%+24.69%+45.55% 304B
-1.15%+0.30%-1.49%+12.31% 252B
-1.55%+1.11%+56.10%+70.32% 236B
-0.88%+1.15%-17.09%-54.39% 206B
-0.15%+3.65%+33.90%+96.99% 187B
Average -0.99%+1.09%+28.30%+51.13% 408.71B
Weighted average by Cap. -1.10%+0.55%+36.62%+66.22%

Financials

2014 2015
Net sales - -
Net income -38.52M -33.14M -31.18M -28.49M -53.29M -3.64B -53.43M -368M -143M -1.87B -145M -141M -6.01B -6.84M -5.89M -5.54M -5.06M -9.47M -646M -9.5M -65.49M -25.41M -332M -25.7M -25.14M -1.07B
Net Debt -45K -38.72K -36.43K -33.28K -62.26K -4.25M -62.43K -431K -167K -2.18M -169K -165K -7.02M 19.86M 17.09M 16.08M 14.69M 27.47M 1.87B 27.55M 190M 73.72M 962M 74.57M 72.94M 3.1B
Logo Star Scientific, Inc.
Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.
Employees
-